A Aforeworn
Forewarned is forearmed.
Home › Niches › Healthcare AI Regulation (FDA / ONC) › Change
Medium urgency

US-CONGRESS HR1520: Charlotte Woodward Organ Transplant Discrimination Prevention Act

Detected September 2, 2026 · in Healthcare AI Regulation (FDA / ONC)

The Charlotte Woodward Organ Transplant Discrimination Prevention Act is under consideration in the Senate, focusing on preventing discrimination in organ transplant allocation based on disability status.

Aforeworn detected this change in the Healthcare AI Regulation (FDA / ONC) space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Health systems, medical device companies, health tech startups, and digital health compliance teams. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Healthcare AI Regulation (FDA / ONC) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

Potential new regulations aimed at preventing discrimination in organ transplant allocation based on disability.

Who it affects

Health systems, medical device companies, health tech startups, and digital health compliance teams.

What you must do

Monitor the progress of the bill and prepare for potential compliance adjustments regarding organ transplant policies.

Deadline

Not specified.

Source: https://www.congress.gov/bill/119th-congress/house-bill/1520

Never miss a change like this again

Aforeworn watches Healthcare AI Regulation (FDA / ONC) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Healthcare AI Regulation (FDA / ONC)